These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Knocking down of the DHFR-TS gene in Toxoplasma gondii using siRNA and assessing the subsequences on toxoplasmosis in mice. Azimi-Resketi M; Eskandarian A; Ganjalikhani-Hakemi M; Zohrabi T Acta Trop; 2020 Jul; 207():105488. PubMed ID: 32277926 [TBL] [Abstract][Full Text] [Related]
27. Screening for small molecule inhibitors of Toxoplasma gondii. Kortagere S Expert Opin Drug Discov; 2012 Dec; 7(12):1193-206. PubMed ID: 22998671 [TBL] [Abstract][Full Text] [Related]
29. Synthesis and biological evaluation of ursolic acid derivatives bearing triazole moieties as potential anti-Toxoplasma gondii agents. Luan T; Jin C; Jin CM; Gong GH; Quan ZS J Enzyme Inhib Med Chem; 2019 Dec; 34(1):761-772. PubMed ID: 30836795 [TBL] [Abstract][Full Text] [Related]
30. Discovery of potential Toxoplasma gondii CDPK1 inhibitors with new scaffolds based on the combination of QSAR and scaffold-hopping method with in vitro validation. Zhang P; Jia L; Tian Y; Xi L; Duan R; Chen X; Xiao J; Yao X; Lan J; Li S Chem Biol Drug Des; 2020 May; 95(5):476-484. PubMed ID: 31436911 [TBL] [Abstract][Full Text] [Related]
31. Imidazo[1,2-b]pyridazines targeting Toxoplasma gondii calcium-dependent protein kinase 1 decrease the parasite burden in mice with acute toxoplasmosis. Moine E; Moiré N; Dimier-Poisson I; Brunet K; Couet W; Colas C; Van Langendonck N; Enguehard-Gueiffier C; Gueiffier A; Héraut B; Denevault-Sabourin C; Debierre-Grockiego F Int J Parasitol; 2018 Jun; 48(7):561-568. PubMed ID: 29524527 [TBL] [Abstract][Full Text] [Related]
32. Prediction of Toxoplasma gondii virulence factor ROP18 competitive inhibitors by virtual screening. Yin K; Zhao G; Xu C; Qiu X; Wen B; Sun H; Liu G; Liu Y; Zhao Q; Wei Q; Huang B; Yan G; Cao J Parasit Vectors; 2019 Mar; 12(1):98. PubMed ID: 30867024 [TBL] [Abstract][Full Text] [Related]
33. Protein targets of thiazolidinone derivatives in Toxoplasma gondii and insights into their binding to ROP18. Molina D; Cossio-Pérez R; Rocha-Roa C; Pedraza L; Cortes E; Hernández A; Gómez-Marín JE BMC Genomics; 2018 Nov; 19(1):856. PubMed ID: 30497375 [TBL] [Abstract][Full Text] [Related]
34. Identification of FDA approved drugs against SARS-CoV-2 RNA dependent RNA polymerase (RdRp) and 3-chymotrypsin-like protease (3CLpro), drug repurposing approach. Molavi Z; Razi S; Mirmotalebisohi SA; Adibi A; Sameni M; Karami F; Niazi V; Niknam Z; Aliashrafi M; Taheri M; Ghafouri-Fard S; Jeibouei S; Mahdian S; Zali H; Ranjbar MM; Yazdani M Biomed Pharmacother; 2021 Jun; 138():111544. PubMed ID: 34311539 [TBL] [Abstract][Full Text] [Related]
36. Characterization of a Toxoplasma gondii calcium calmodulin-dependent protein kinase homolog. Kato K; Sugi T; Takemae H; Takano R; Gong H; Ishiwa A; Horimoto T; Akashi H Parasit Vectors; 2016 Jul; 9(1):405. PubMed ID: 27444499 [TBL] [Abstract][Full Text] [Related]
37. Deciphering ophthalmic adaptive inhibitors targeting RON4 of Toxoplasma gondii: An integrative in silico approach. Vetrivel U; Nagarajan H Life Sci; 2018 Nov; 213():82-93. PubMed ID: 30326220 [TBL] [Abstract][Full Text] [Related]
38. Pneumocystis carinii and Toxoplasma gondii dihydrofolate reductase inhibitors and antitumor agents: synthesis and biological activities of 2,4-diamino-5-methyl-6-[(monosubstituted anilino)methyl] pyrido[2,3-d]pyrimidines. Gangjee A; Adair O; Queener SF J Med Chem; 1999 Jul; 42(13):2447-55. PubMed ID: 10395486 [TBL] [Abstract][Full Text] [Related]
39. Two old drugs, NVP-AEW541 and GSK-J4, repurposed against the Toxoplasma gondii RH strain. Liu S; Wu M; Hua Q; Lu D; Tian Y; Yu H; Cheng L; Chen Y; Cao J; Hu X; Tan F Parasit Vectors; 2020 May; 13(1):242. PubMed ID: 32393321 [TBL] [Abstract][Full Text] [Related]
40. Targeted Structure-Activity Analysis of Endochin-like Quinolones Reveals Potent Qi and Qo Site Inhibitors of Toxoplasma gondii and Plasmodium falciparum Cytochrome bc McConnell EV; Bruzual I; Pou S; Winter R; Dodean RA; Smilkstein MJ; Krollenbrock A; Nilsen A; Zakharov LN; Riscoe MK; Doggett JS ACS Infect Dis; 2018 Nov; 4(11):1574-1584. PubMed ID: 30117728 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]